Health
Results: 8185-8196 of 9396

ReLive Biotechnologies Announces NDA Approval of SpheChon 10-70 spheroids/cm² by the HSA in Singapore, Marking a Milestone in ReLive’s Global Endeavors

Biocytogen Launches RenBiologics, A Sub-Brand Focused on Out-Licensing Fully Human Antibodies For Therapeutic Development

Crown Bioscience's Global Oncology Research Facilities Achieve Prestigious ISO and CAP Accreditations

Patient, Research and Industry Leaders Propose Biological Definition and First Biological Staging for Parkinson's Disease






